Current Assets Zmiana Data
AbbVie USD 33.22B 4.37B 2023-09
Abbott USD 23.51B 872M 2023-06
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Baxter International USD 9.6B 2.43B 2023-12
Bayer EUR 37.53B 1.25B 2023-09
Becton, Dickinson and Co. USD 8.16B 520M 2023-12
Biogen USD 6.86B 1.59B 2023-12
Boston Scientific USD 6.5B 618M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
CONMED USD 625.65M 10.13M 2023-09
Cooper Companies USD 1.79B 89M 2023-12
Dexcom USD 4.43B 272.5M 2023-12
Edwards Lifesciences USD 4.04B 31.8M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Globus Medical USD 1.92B 1.96M 2023-12
Hologic USD 3.49B 690.3M 2023-12
Insulet USD 1.58B 111.8M 2023-12
Integra LifeSciences USD 1.06B 30.81M 2023-12
Intuitive Surgical USD 9.69B 791.1M 2023-12
J&J USD 53.7B 6.86B 2023-09
Merck USD 31.95B 1.98B 2023-09
Merit Medical Systems USD 1.11B 523.15M 2023-12
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Stryker USD 12.49B 1.44B 2023-12
Tandem Diabetes Care USD 747.99M 10.15M 2023-12
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Zimmer Biomet Holdings USD 4.61B 237.5M 2023-12
Zoetis USD 6.34B 121M 2023-12



J&J Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.